| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 05/13/1997 | US5628986 Oral compositions |
| 05/13/1997 | US5628984 Composition to promote lung mucus secretions |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016196A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 05/09/1997 | CA2236207A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 05/07/1997 | EP0771562A2 Improved preparation for colonic evacuation |
| 05/07/1997 | EP0771207A1 Use of magnesium hydroxide as a stool softener |
| 05/07/1997 | EP0771203A1 Method of treating sweat-related conditions |
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1148986A New skin preparation composition |
| 05/07/1997 | CN1148975A Ointment for anti-inflammatory and curing burn |
| 05/07/1997 | CN1148969A Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing |
| 05/06/1997 | US5626904 Salt product and a method for the preparation thereof |
| 05/06/1997 | US5626884 Treatment of sickle cell disease |
| 05/06/1997 | US5626880 Infusion preparation |
| 05/06/1997 | US5626865 Enzyme-orthokeratology |
| 05/06/1997 | US5626825 Process for the purification of magnesium hydroxide |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0544760B1 Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders |
| 05/01/1997 | WO1997015661A1 Microporous pathogen-killing composition |
| 05/01/1997 | WO1997015595A1 Method of mobilizing hematopoietic stem cells |
| 05/01/1997 | WO1997015328A1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 05/01/1997 | WO1997015314A1 Vaginal pharmaceutical compositions containing a peroxide source |
| 05/01/1997 | WO1997015313A1 Therapeutic use of hemoglobin in promoting wound healing |
| 05/01/1997 | WO1997015312A1 Nitrogen monoxide composition for use as a drug |
| 05/01/1997 | WO1997015311A1 Nitrogen monoxide composition for use as a drug |
| 05/01/1997 | WO1997015289A1 Solubilisation methods |
| 05/01/1997 | WO1997015282A1 Compositions for the treatment of dermatological disorders and methods for their use |
| 05/01/1997 | CA2235548A1 Therapeutic use of hemoglobin in promoting wound healing |
| 05/01/1997 | CA2235487A1 Solubilisation methods |
| 05/01/1997 | CA2235122A1 Nitrogen monoxide composition for use as a drug |
| 04/30/1997 | CN1148808A Anti-acne composition |
| 04/30/1997 | CN1148499A Medicine for reducing blood-pressure and preparation method thereof |
| 04/29/1997 | US5624908 Antineoplastic compositions |
| 04/29/1997 | US5624675 Genital lubricants containing zinc salts to reduce risk of HIV infection |
| 04/29/1997 | US5624668 Iron dextran formulations |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014423A1 Medicament for treating arterial occlusive vascular diseases, micro-angiopathies and micro-circulatory disturbances |
| 04/24/1997 | WO1997014397A1 A depilatory composition with improved rinsing properties |
| 04/24/1997 | DE19538666A1 Arzneimittel zur Behandlung von arteriellen VerschluĂkrankheiten, Mikroangiopathien und Mikrozirkulationsstörungen Drugs for treatment of arterial occlusive diseases, microangiopathy and microcirculatory disturbances |
| 04/23/1997 | EP0769300A2 Antiemetic composition containing an NK-1 receptor antagonists |
| 04/23/1997 | EP0769291A1 Active agent combination against acne and inflamed comedones |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0768887A1 Compositions having antiviral properties and preparation process |
| 04/23/1997 | EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds |
| 04/23/1997 | CN1147955A Traditional Chinese medicine powder for bone-setting, and method for preparing same |
| 04/23/1997 | CN1147938A Liquid for giving up smoking |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/22/1997 | US5622848 Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| 04/22/1997 | US5622725 Wound disinfection and repair |
| 04/22/1997 | US5622724 Spraying aqueous or saline solution containing zinc sulfate or zinc chloride to the nostrils or respiratory track of a patient suffering from common cold |
| 04/22/1997 | US5622686 Diagnosis and treatment of viral effects using magnetic metal transferrin particles |
| 04/22/1997 | CA2015235C Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent |
| 04/21/1997 | CA2188238A1 Injectable gaseous no/co2 composition |
| 04/17/1997 | WO1997005870A3 Use of griseofulvin for inhibiting the growth of cancers |
| 04/16/1997 | EP0767677A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 04/16/1997 | CN1147768A Compositions comprising DNA damaging agents and P53 |
| 04/15/1997 | US5620967 Administering bis(maltolato)oxovanadium(iv) |
| 04/15/1997 | US5620527 Cleansing and disinfecting method |
| 04/10/1997 | WO1997012620A1 Method and composition for treatment of osteoporosis |
| 04/10/1997 | WO1997012607A1 Chewing gum product with plaque-inhibiting benefits |
| 04/10/1997 | WO1997012590A1 ULTRAVIOLET-PROTECTING COSMETIC COMPOSITIONS CONTAINING TiO2 NANOPIGMENTS AND AN ACYLAMINOACID |
| 04/10/1997 | WO1997009998A3 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 04/10/1997 | WO1997006798A3 Pharmaceutical formulations |
| 04/09/1997 | EP0766964A1 Use of orotic acid for the preparation of a medicament for protection of membranes and endothel |
| 04/09/1997 | EP0766959A1 Cosmetic sunscreening compositions containing TiO2 nanopigments and an acrylaminoacid |
| 04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 04/09/1997 | EP0693878B1 Iodine barrier teat dip |
| 04/09/1997 | CN1147204A Use of spiramycin for treating |
| 04/09/1997 | CN1146903A Prescription of Chinese medicine for treating cholecystitis, cholelithiasis, hepatitis and cholehepatocirrhosis |
| 04/08/1997 | US5618925 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 04/08/1997 | US5618847 Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish |
| 04/08/1997 | US5618838 Administering gallium complex of desferrioxamine or penicillamine to treat ischemic insult, thalassemia, hemochromatosis, wilson*s disease, paraquat toxicity |
| 04/08/1997 | US5618799 Storage stability, noncaking, nonscattering, adhesion |
| 04/08/1997 | US5618798 Use of sucralfate to treat baldness |
| 04/08/1997 | US5618564 Composition for the treatment of helicobacter pylori infection |
| 04/08/1997 | US5618550 Method for treatment of abnormal conditions of the epithelium of bodily orifices |
| 04/08/1997 | US5618549 Bone diseases such as osteoporosis |
| 04/08/1997 | US5618339 Substance prepared from animal bones by liming, neutralization, thermal extraction, condensation, dehydration to obtain gelatin which is deproteinized through non-heat or low temperature process |
| 04/03/1997 | WO1997011711A1 Iron dextran formulations |
| 04/02/1997 | EP0765289A1 Process and filter for producing no 2?-free nitrogen monoxide with sulphurous polymers |
| 04/02/1997 | EP0765163A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 04/02/1997 | EP0683661B1 Cosmetic and dermatological photoprotective formulations containing inorganic micro-pigments |
| 04/02/1997 | EP0455706B1 A medicinal substance for topical application |
| 04/02/1997 | CN1146353A Capsule and ointment for skin diseases |
| 04/02/1997 | CN1146352A Gujinkang traditional Chinese medicine and preparation method |
| 04/02/1997 | CN1146338A Stable cross-linked compound of polyvinyl pyrrolidone and iodine and method for preparation of said compound |
| 04/01/1997 | US5616347 Chlorine dioxide skin medicating compositions for preventing irritation |
| 04/01/1997 | US5616346 Sodium phosphate mixtures |
| 04/01/1997 | US5616335 Mixture of organic peroxy acid, copolymeric ethylene oxide-propylene oxide thickener and isocyanate, for applying to human or animal skins or mucous membranes |
| 04/01/1997 | US5616324 Pro-inflammatory composition comprising at least two members of the group consisting of DL. phenylalanine, ruta graveolans and corydalis bulbosda |
| 04/01/1997 | US5616313 Method for treating gingival and periodontal tissues |
| 04/01/1997 | US5616248 Method for the preparation of hemodialysis fluids containing bicarbonate |
| 04/01/1997 | CA1339031C Method of preserving ophthalmic solutions and compositions therefor |
| 03/27/1997 | WO1997010802A1 Topical formulations and delivery systems |
| 03/27/1997 | WO1997001344A3 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |